Related Experiment Video
Updated: Mar 15, 2026

Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes
Published on: September 1, 2018
Prodigiosin - A Multifaceted Escherichia coli Antimicrobial Agent
Tjaša Danevčič1, Maja Borić Vezjak1, Maša Zorec2
1Laboratory of Microbiology, Department of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Prodigiosin, a natural compound, inhibits bacterial growth by affecting outer membranes and essential synthesis processes. It acts as a bacteriostatic agent, hindering bacterial division without causing cell death.
Area of Science:
- Microbiology
- Bacteriology
- Biochemistry
Background:
- Prodigiosin is a microbial pigment with known bioactivity, but its precise antibacterial mechanism remains unclear.
- Understanding prodigiosin's effects on bacterial physiology is crucial for its potential therapeutic applications.
Purpose of the Study:
- To elucidate the antimicrobial mechanism of prodigiosin against Escherichia coli.
- To investigate the concentration-dependent effects of prodigiosin on bacterial cellular processes.
Main Methods:
- Escherichia coli cultures were treated with varying concentrations of prodigiosin.
- Analysis included assessments of DNA integrity, membrane permeability, respiration, protein and RNA synthesis, and cell division.
- Bacterial survival rates were tested in the presence of antibiotics.
Main Results:
- Prodigiosin exhibited concentration-dependent effects, with outer membrane leakage observed above the minimum inhibitory concentration (MIC).
- Significant inhibition of respiration, protein, and RNA synthesis occurred, leading to cell elongation without division.
- Prodigiosin pre-treatment enhanced E. coli survival against certain antibiotics (ampicillin, kanamycin, erythromycin) but not phleomycin.
- Bacterial growth resumed upon prodigiosin dilution, indicating a reversible, bacteriostatic effect.
Conclusions:
- Prodigiosin acts as a bacteriostatic agent in Escherichia coli, primarily by disrupting the outer membrane and inhibiting key cellular synthesis.
- The compound's mode of action appears distinct in different bacterial species, warranting further investigation.
- Prodigiosin demonstrates potential for synergistic effects with some conventional antibiotics.
More Related Videos
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
07:59Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor
Published on: June 29, 2021
Related Concept Videos
Antibiotic Selection
Stringent Response in E. coli
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...